Patents by Inventor Michael Moller

Michael Moller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10314913
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: June 11, 2019
    Assignee: UNIVERSITY OF GENEVA
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Publication number: 20180271984
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: February 14, 2018
    Publication date: September 27, 2018
    Applicant: UNIVERSITY OF GENEVA
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Patent number: 9925267
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 27, 2018
    Assignee: University of Geneva
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Publication number: 20160367680
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 22, 2016
    Applicant: UNIVERSITY OF GENEVA
    Inventors: Michael MOLLER, Thomas TRIMAILLE, Robert GURNY
  • Patent number: 9375482
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: June 28, 2016
    Assignee: University of Geneva
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Publication number: 20150073060
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: April 22, 2014
    Publication date: March 12, 2015
    Applicant: UNIVERSITY OF GENEVA
    Inventors: Michael MOLLER, Thomas TRIMAILLE, Robert GURNY
  • Publication number: 20140335135
    Abstract: Sustained release formulations of triptorelin are provided.
    Type: Application
    Filed: December 5, 2012
    Publication date: November 13, 2014
    Applicant: FERRING BV
    Inventors: Michael Moller, Robert Gurny, Asmus Lutz, Gregoire Schwach
  • Patent number: 8741877
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: June 3, 2014
    Assignee: University of Geneva
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Publication number: 20130281637
    Abstract: A fatty acid derivative-polymer conjugate including a conjugate comprising a fatty acid derivative and an alkyl substituted polylactide compound is provided. A pharmaceutical composition comprising the conjugate is also provided.
    Type: Application
    Filed: April 19, 2013
    Publication date: October 24, 2013
    Applicant: Sucampo AG
    Inventors: Ryuji UENO, Peter LICHTLEN, Robert GURNY, Michael MOLLER
  • Publication number: 20130281638
    Abstract: A tricycle compound-polymer conjugate including a conjugate comprising a tricyclo compound and an alkyl substituted polylactide compound is provided. A pharmaceutical composition comprising the conjugate is also provided.
    Type: Application
    Filed: April 19, 2013
    Publication date: October 24, 2013
    Applicant: SUCAMPO AG
    Inventors: Ryuji UENO, Peter LICHTLEN, Robert GURNY, Michael MOLLER
  • Patent number: 8466133
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: June 18, 2013
    Assignee: University of Geneva
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Publication number: 20090281068
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 12, 2009
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny